RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

43 hedge funds and large institutions have $146M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$88.8M
2
$12.6M
3
$6.35M
4
$6.05M
5
$4.04M
6
$3.95M
7
$3.71M
8
$3.36M
9
$2.52M
10
$2.51M
11
$1.63M
12
$1.44M
13
$1.42M
14
$1.39M
15
$1.24M
16
$754K
17
$576K
18
$411K
19
$410K
20
$317K
21
$300K
22
$290K
23
$264K
24
$240K
25
$236K